Evidence map›Paper›PMID 31691893›Full record

ReviewPituitary2020

Surgical indications for pituitary tumors during pregnancy: a literature review.

Thomas Graillon, Thomas Cuny, Frédéric Castinetti, Blandine Courbière, Marie Cousin, Frédérique Albarel, Isabelle Morange, Nicolas Bruder, Thierry Brue, Henry Dufour

Abstract readReview
PubMed Publisher
In one paragraph

Review in Pituitary, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Challenges of Pituitary Apoplexy in Pregnancy.Journal of clinical medicine · 2023
    Review
  7. Pituitary Apoplexy in Pregnancy: What do We Know?Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia · 2023
    Review
  8. Surgical management of pituitary adenoma during pregnancy.World journal of clinical cases · 2023
    Article
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Thomas GraillonNeurosurgery Department, Aix-Marseille Univ, APHM, CHU Timone, La Timone Hospital, 264 rue Saint-Pierre, 13005, Marseille, France. Thomas.Graillon@ap-hm.fr.ORCID http://orcid.org/0000-0001-5627-8181
Thomas CunyAix-Marseille Univ, INSERM, MMG, Marseille, France.
Frédéric CastinettiAix-Marseille Univ, INSERM, MMG, Marseille, France.
Blandine CourbièreCentre Clinico-Biologique d'AMP, Pôle Femmes-Parents-Enfants, Hôpital de La Conception, AP-HM, Marseille/Aix Marseille Univ, Avignon Univ, CNRS, IRD, IBME, Marseille, France.
Marie CousinCabinet d'Ophtalmologie, Saint-Rémy de Provence, France.
Frédérique AlbarelEndocrinology Department, Aix-Marseille Univ, APHM, CHU Conception, Marseille, France.
Isabelle MorangeEndocrinology Department, Aix-Marseille Univ, APHM, CHU Conception, Marseille, France.
Nicolas BruderAnesthesiology-Intensive Care Department, Aix-Marseille Univ, APHM, CHU Timone, Marseille, France.
Thierry BrueAix-Marseille Univ, INSERM, MMG, Marseille, France.
Henry DufourNeurosurgery Department, Aix-Marseille Univ, APHM, CHU Timone, La Timone Hospital, 264 rue Saint-Pierre, 13005, Marseille, France.
Inserm · FRAix-Marseille Université · FRCentre National de la Recherche Scientifique · FRLaboratoire interdisciplinaire Récits Cultures et Sociétés

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeSurgical indications for pituitary tumors during pregnancy are rare, and are derived from a balance between expected benefits, particularly for maternal benefits, and anesthetic/surgical risks.

methodsA literature review was performed to define the optimal surgical indications for pituitary adenomas (PA) and other pituitary tumors during pregnancy.

resultsMain benefits are expected in case of critical visual impairment and/or life-threatening endocrine disturbances. Multidisciplinary patient management is systematically required although nonobstetric surgery presents a reasonable risk during pregnancy. The risks of congenital malformation during the first trimester and those of premature birth during the third trimester make the second trimester the optimal period for surgery. In prolactin-secreting, nonsecreting, GH- and TSH-secreting PAs, transsphenoidal surgery (TS) is recommended in cases involving severe visual impairment, characterized by severe visual field deficit, visual acuity impairment, and abnormal optical coherence tomography findings, and when no other medical alternatives are possible and/or sufficient. Uncontrolled and severe Cushing's disease (CD) during pregnancy increases both maternal and fetal morbimortality, thus justifying TS or sometimes dopamine agonist therapy as a safer alternative. Finally, metyrapone, ketoconazole, or bilateral adrenalectomy could be recommended in certain cases after the failure of medical therapies and/or TS. Surgery is also required for suprasellar meningiomas, craniopharyngiomas, and pituitary cysts in the case of severe visual deficit.

conclusionSurgical indications for pituitary tumors are rare during pregnancy; therefore, surgery should be avoided when possible. Further, the second trimester should be considered as the optimal surgical period. Severe visual disturbance and uncontrolled CD are the main surgical indications during pregnancy.

Indexed as

CraniopharyngiomaFemaleHumansMeningiomaPituitary ACTH HypersecretionPituitary NeoplasmsPregnancyCraniopharyngiomaMeningiomaPituitary adenomaPituitary cystPregnancySurgery

Identifiers

PMID31691893
OpenAlexW2984263335

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.